Literature DB >> 1754389

Self-cleavage of a 71 nucleotide-long ribozyme derived from hepatitis delta virus genomic RNA.

G Thill1, M Blumenfeld, F Lescure, M Vasseur.   

Abstract

Self-cleavage efficiency of ribozymes derived from hepatitis delta virus (HDV) has been shown to depend on the RNA structure, which in turn may be determined by the length of the considered sequences. Here we describe the construction and functional analysis of a 71 nucleotide-long RNA genomic fragment, Rz71, which carries an 18 nucleotide deletion in a very stable GC-rich stem-loop (stem IV), predicted to be present in several computer-derived secondary structure models. Rz71 is able to undergo self-cleavage under non-denaturing conditions (the t1/2 of the reaction at 37 degrees C is 3 min). The deletion, however, is not neutral, since under the same conditions the non-deleted ribozyme cleaves to 50% in less than 15 sec. Therefore, stem-loop IV seems to play a structural role, not being directly involved in the catalytic reaction, but contributing to the correct positioning of the catalytic core of the HDV ribozyme. Rz71 is the smallest self-cleaving sub-fragment of HDV genomic RNA reported so far.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1754389      PMCID: PMC329210          DOI: 10.1093/nar/19.23.6519

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions.

Authors:  S P Rosenstein; M D Been
Journal:  Biochemistry       Date:  1990-09-04       Impact factor: 3.162

2.  The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant.

Authors:  A T Perrotta; M D Been
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

3.  Non-ribozyme sequences enhance self-cleavage of ribozymes derived from Hepatitis delta virus.

Authors:  M G Belinsky; G Dinter-Gottlieb
Journal:  Nucleic Acids Res       Date:  1991-02-11       Impact factor: 16.971

4.  A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA.

Authors:  A T Perrotta; M D Been
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

Review 5.  Human hepatitis delta virus.

Authors:  J M Taylor
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

6.  Synthesis of small RNAs using T7 RNA polymerase.

Authors:  J F Milligan; O C Uhlenbeck
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

7.  Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus.

Authors:  M Y Kuo; L Sharmeen; G Dinter-Gottlieb; J Taylor
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

8.  Self-ligating RNA sequences on the antigenome of human hepatitis delta virus.

Authors:  L Sharmeen; M Y Kuo; J Taylor
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

9.  Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

Authors:  M Rizzetto; M G Canese; S Aricò; O Crivelli; C Trepo; F Bonino; G Verme
Journal:  Gut       Date:  1977-12       Impact factor: 23.059

10.  Human hepatitis delta virus RNA subfragments contain an autocleavage activity.

Authors:  H N Wu; Y J Lin; F P Lin; S Makino; M F Chang; M M Lai
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

View more
  9 in total

1.  Random mutations to evaluate the role of bases at two important single-stranded regions of genomic HDV ribozyme.

Authors:  P K Kumar; Y A Suh; H Miyashiro; F Nishikawa; J Kawakami; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

2.  Deletion of internal sequence on the HDV-ribozyme: elucidation of functionally important single-stranded loop regions.

Authors:  Y A Suh; P K Kumar; F Nishikawa; E Kayano; S Nakai; O Odai; S Uesugi; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  3-D models of the antigenomic ribozyme of the hepatitis delta agent with eight new contacts suggested by sequence analysis of 188 cDNA clones.

Authors:  A D Branch; J A Polaskova
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

4.  A circular trans-acting hepatitis delta virus ribozyme.

Authors:  M Puttaraju; A T Perrotta; M D Been
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

5.  Self-cleavage activity of the genomic HDV ribozyme in the presence of various divalent metal ions.

Authors:  Y A Suh; P K Kumar; K Taira; S Nishikawa
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

6.  Assessment of disparate structural features in three models of the hepatitis delta virus ribozyme.

Authors:  A T Perrotta; M D Been
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

7.  Folding of the HDV antigenomic ribozyme pseudoknot structure deduced from long-range photocrosslinks.

Authors:  C Bravo; F Lescure; P Laugâa; J L Fourrey; A Favre
Journal:  Nucleic Acids Res       Date:  1996-04-01       Impact factor: 16.971

8.  Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Stephanie T Shi; Koleen J Herlihy; Joanne P Graham; Jim Nonomiya; Sadayappan V Rahavendran; Heather Skor; Rebecca Irvine; Susan Binford; John Tatlock; Hui Li; Javier Gonzalez; Angelica Linton; Amy K Patick; Cristina Lewis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

9.  Development of intergenotypic chimeric replicons to determine the broad-spectrum antiviral activities of hepatitis C virus polymerase inhibitors.

Authors:  Koleen J Herlihy; Joanne P Graham; Robert Kumpf; Amy K Patick; Rohit Duggal; Stephanie T Shi
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.